statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analyst Ratings For IDEXX Laboratories

Latest Ratings for IDXX
 DateFirmActionFromTo Feb 2022Atlantic EquitiesInitiates Coverage OnOverweight Nov 2021Morgan StanleyInitiates Coverage OnOverweight Aug 2021Credit SuisseMaintainsOutperform...

IDEXX Laboratories to Release 2024 Second Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market...

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis

IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in...

IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane...

Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst

IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024...

IDEXX Laboratories Announces First Quarter Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company reports revenues of $964 million for...

Chevy Chase Trust Holdings LLC Trims Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Chevy Chase Trust Holdings LLC lowered its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the SEC...

Forza Wealth Management LLC Sells 1,200 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Forza Wealth Management LLC lessened its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) by 75.0% in the fourth quarter, according to the company in its most recent 13F filing with the...

IDEXX Laboratories to Release 2024 First Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens...

Integrated Investment Consultants LLC Invests $251,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX)

Integrated Investment Consultants LLC acquired a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX - Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 453 shares of the...

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.

Volume	588,415.00
52-Wk High	$583.39
52-Wk Low	$372.50

IDXX Idexx Laboratories, Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals